Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03873467 · ClinicalTrials.gov registry record · NA
Group Lifestyle Balance™ for Individuals With Stroke (GLB-CVA)
A NA study of Stroke, sponsored by Baylor Research Institute.
- Active
- Registry status
- NA
- Development phase
- 65
- Enrollment target
- 1
- Study location
NCT03873467: Active NA study of Stroke, sponsored by Baylor Research Institute.
NCT03873467 is a NA study of Stroke that is active but no longer recruiting, run by Baylor Research Institute. The registered enrollment target is 65 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03873467, a NA study of Stroke, is active but no longer recruiting, sponsored by Baylor Research Institute.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this RCT is to examine the efficacy of the Group Lifestyle Balance (GLB) program adapted for people with stroke (CVA) on primary (weight) and secondary outcomes at 3, 6, 12 months from enrollment into the program.
Primary Outcome
Will be obtained using the same scale over the study period that is accessible to people with and without a mobility device (e.g., walker; wheelchair).
Conditions Studied
Interventions
- OTHER Usual Care
- BEHAVIORAL Group Lifestyle Balance
Study Locations (1)
Texas
- Baylor Scott & White Institute for Rehabilitation - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2019-07-08 |
| Est. Completion | 2026-12-30 |
| Phase | NA |
What the registry record for NCT03873467 still lists
NCT03873467 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 65 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.
NCT03873467 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03873467 about?
NCT03873467 is a clinical study titled "Group Lifestyle Balance™ for Individuals With Stroke (GLB-CVA)". The purpose of this RCT is to examine the efficacy of the Group Lifestyle Balance (GLB) program adapted for people with stroke (CVA) on primary (weight) and secondary outcomes at 3, 6, 12 months from enrollment into the program.
What is the current status of trial NCT03873467?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 65 participants. The study started on 2019-07-08. Estimated completion is 2026-12-30.
What conditions does trial NCT03873467 study?
This clinical trial studies the following conditions: Stroke.
What interventions are being tested in trial NCT03873467?
The interventions under investigation include: Usual Care (OTHER), Group Lifestyle Balance (BEHAVIORAL).
Who is sponsoring clinical trial NCT03873467?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03873467 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03873467's enrollment target sits among peer trials
65 195th of 454 higher than 258 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
-
Safety and Feasibility of an ExoNET for Supination Assistance for Stroke Survivors
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI